Announcements Trials

Browse Landscape

Phase

Phase 1 2 Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 2 Skin Neoplasms 1 Neoplasms 1

Interventions

Sirolimus 3 aldesleukin 2 Tacrolimus 2 Cyclosporine 2 relatlimab 1 oxycodone-acetaminophen 1 abobotulinumtoxinA 1 Vemurafenib 1 Sodium Chloride 1 Prednisone 1 Nivolumab 1 Mycophenolic Acid 1 Meloxicam 1 Ipilimumab 1 Interleukins 1 Interleukin-2 1 Fluorouracil 1 Everolimus 1 Bleomycin 1 Azathioprine 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Skin Neoplasms × Vemurafenib × Clear all

NCT01683188 2021-02-01

PROCLIVITY01

Clinigen, Inc.

Phase 4 Terminated

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡